Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy. Clinics [Internet]. 2021 Oct. 11 [cited 2024 May 20];76:e3146. Available from: https://revistas.usp.br/clinics/article/view/212977